Last reviewed · How we verify
COVID-19 and Cancer Patients (OnCovid)
Routinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.
Details
| Lead sponsor | Imperial College London |
|---|---|
| Status | COMPLETED |
| Enrolment | 3820 |
| Start date | Wed Apr 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Cancer
- Sars-CoV2
Countries
France, Italy, Belgium, United Kingdom, Germany, Spain